Hinge Health's Q1 2026 Earnings: Migraine Care & Scalability

Hinge Healths Q1 2026 earnings report is a scorcher, with revenue surging 47% to $182 million, exceeding guidance by $11 million. They posted an 85% gross margin, 25% operating margin, and $42 million in free cash flow, a tenfold increase from last year. Their new migraine care program, using the FDA-cleared Enso device, is gaining traction with 125 clients covering 2 million lives. The company raised full-year guidance, expecting 36% revenue growth and a 26% operating margin. Hinge Health is poised to expand its platform across conditions, with their annual Movement conference in Chicago on June 10th. Support the show:Get a discount at https://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/e41db79fb3faf08f